Navigation Links
ECRI Institute Names Kaiser Permanente Winner of 5th Annual Health Devices Achievement Award
Date:10/11/2010

PLYMOUTH MEETING, Pa., Oct. 11 /PRNewswire-USNewswire/ -- ECRI Institute® (www.ecri.org), an independent nonprofit organization that researches the best approaches to improving patient care, is pleased to announce Kaiser Permanente (www.kp.org), a leading healthcare provider and not-for-profit health plan,  as the winner of the 5th annual Health Devices Achievement Award for excellence in health technology management. The Health Devices Achievement Award recognizes an outstanding initiative undertaken by an ECRI Institute member healthcare institution that improves patient safety, reduces costs, or otherwise facilitates better strategic management of health technology.  

Kaiser Permanente's winning submission describes its groundbreaking initiatives, the National Total Joint Replacement Registry (TJRR) and the Cardiac Device Registry (CDR).These are comprehensive databases covering almost 150,000 joint-replacement and cardiac implants from regions across the United States. The registries allow the analysis of implant statistics, including complications, failures, replacements, usage, and costs. Mining these data identifies the most effective devices and surgical techniques, as well as patients who are at risk for re-operations and surgical complications.

"Our award evaluation committee was extremely impressed with how many ways the registries can be used to improve quality of care throughout Kaiser Permanente and at a national and even international level," says James P. Keller, Jr., ECRI Institute's Vice President for Health Technology Evaluation and Safety.  "Kaiser Permanente's registries are extremely impactful.  ECRI Institute is pleased to recognize such important work with our award."

Kaiser Permanente's project, 10 years in development, represents an unprecedented partnership between the surgeons who use implants and the hospital
'/>"/>

SOURCE ECRI Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ACD Wins $3 Million Grant From National Cancer Institute to Develop Its CTCscope™ System for Detection and Molecular Analysis of Circulating Tumor Cells
2. Bexion Pharmaceuticals Continues to Gain Support from National Cancer Institute (NCI)
3. Star Scientific Comments on Roskamp Institutes Plans to Conduct Human Alzheimers Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.
4. West Wireless Health Institute Awards $10K Developer Challenge at Health 2.0
5. Roskamp Institute to Begin Human Alzheimers Clinical Trials With a Natural Compound in Tobacco
6. American College of Surgeons Health Policy Research Institute Releases Surgery Workforce Atlas That Shows Surgeon Shortage Across the U.S.
7. Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100.
8. The Colorado Institute for Drug, Device and Diagnostic Development Announces Companies Selected From Its First Solicitation: Sophono, Inc., Receiving $600K; and PeptiVir, Inc., $300K
9. National Pharmaceutical Council Comments on Patient-Centered Outcomes Research Institute Board of Governors
10. Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources
11. National Institutes of Health Chooses ScriptPro for Pharmacy Automation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)...  Unichem Pharmaceuticals ( USA ), Inc. ... 25 mg 1000-count bottle to the consumer level. This ... to the identification of a Clopidogrel tablet found in ... risk associated with mistakenly taking a Clopidogrel tablet instead ... experiencing Clopidogrel,s side effects which include bleeding and/or bruising. ...
(Date:7/30/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced the ... of Warburg Pincus LLC, to the Amgen Board of Directors. ... Hassan and the deep, global experience he brings in ... A. Bradway , chairman and chief executive officer of Amgen. "Fred,s ... Amgen well." Mr. Hassan has been Partner and ...
(Date:7/30/2015)...  Growth of the U.S. nonprescription market is primarily ... users to the OTC market. Due to an increasingly ... switch activity over the next five years with several ... brands entering the market into existing categories. ... (even those with low to moderate likelihood), the market ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or ... marketing and sale of medical devices and homecare medical ... Weibing Yang as and Dr. Genhui Chen directors of ... fills the vacancy resulting from the resignation of Ms. ...
...  Researchers have published the largest single patient population ... patients with retrievable inferior vena cava (IVC) filters—devices ... the lungs. This study, which is important for ... existing guidelines developed by the Society of Interventional ...
Cached Medicine Technology:Dehaier Medical Announces Changes to Board of Directors 2Dehaier Medical Announces Changes to Board of Directors 3IVC Filters: Society of Interventional Radiology Leads in Patient Care, Safety, Research 2IVC Filters: Society of Interventional Radiology Leads in Patient Care, Safety, Research 3IVC Filters: Society of Interventional Radiology Leads in Patient Care, Safety, Research 4
(Date:7/31/2015)... VA (PRWEB) , ... July 31, 2015 , ... ... is a one-day event geared to patients and family members, medical professionals, and ... and regional mesothelioma experts. The conference is a collaborative effort between the Mesothelioma ...
(Date:7/31/2015)... ... July 31, 2015 , ... Creating one of the most ... pursuit of a visionary image that goes beyond the boundaries of fertility medicine. ... has reached extraordinary heights with dependable patient support, affordable treatments, unending hope, and high ...
(Date:7/31/2015)... ... July 31, 2015 , ... Girl Scouts of Historic ... across Georgia through the Girl Scout "Be a Friend First" program. Representatives from Peach ... 30. , “Peach State Health Plan and our parent company, Centene Corporation, are ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The Mount Sinai ... research projects that evaluate the potential of related, experimental treatments. The collaboration moves into ... Health to award Columbia Care one of five state licenses to produce and dispense ...
(Date:7/31/2015)... ... , ... BioViva USA, Inc. (“BioViva”), a to-clinic gene therapy company based in ... announces it has begun a fundraiser through Maximum Life Foundation (“MaxLife”) to use a ... MaxLife will grant 100% of the money raised to BioViva to help bring pioneering ...
Breaking Medicine News(10 mins):Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3
... A new study has revealed that one in ten people ... obesity. Earlier research that located the gene variant and // ... it was still ambiguous, whether people without the gene variant ... the link and understand it better, the researchers targeted the ...
... A research symposium titled ‘Challenging Intellectual Property’ will be ... York.// ,The Symposium will look into the ... of knowledge production in economic development. It will also ... on the table, desirous of bringing a change in ...
... famous saying that women buy for fun while men buy ... women may have more foot-healthy and comfortable// options this spring. ... heels, flat shoes and wedge heels. ,Dr. ... at Baylor University Medical Center at Dallas and president of ...
... medical services in Andhra Pradesh came to a ... strike enters the second day. ,Patients had ... services. Patients seeking immediate medical assistance had to ... at the Osmania General Hospital and the Gandhi ...
... Surgeons have now found a new surgical approach termed ... involuntary loss of urine//. It is a post operative ... a condition in which the vagina and the neighboring ... ,Most women who undergo the pelvic surgery are ...
... mistakes but what matters to the brain is the severity ... that is committed// by a person affects the brain. University ... human brain the instant a costly mistake occurs. Dr. Stephan ... the research said that the experiment was carried on to ...
Cached Medicine News:Health News:Doctors Strike In Andhra Enters The Second Day 2Health News:Two-In One Approach To Prevent Incontinence After Prolapse Surgery 2
... The Maxxis™ 300 is a healthcare ... safety for individuals in the home care ... 600 lbs.(or combined weight of 2) ... depending on frame size selected, ,CONTRAINDICATIONS: ...
EC+ Extra Care Bariatric Bed...
... Excel Care ES bed is especially designed ... empowered, while protecting the caregivers who manage them. ... the most routine tasks pulling up in ... to caregivers and disheartening for patients. Excel Care ...
... Disposable Prefilled 28%-100% FIO 2 500ML 0.45% ... nebulizers provide unmatched performance and ease of use. ... adjustable from 28% to 100% FIO 2 . ... water for inhalation, USP; 0.45% sodium chloride inhalation, ...
Medicine Products: